Get the Stockscreener App
18.72
0.48%
0.09
After Hours:
18.72
Mediwound Ltd stock is traded at $18.72, with a volume of 40,836.
It is up +0.48% in the last 24 hours and down -6.54% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.63
Open:
$18.57
24h Volume:
40,836
Relative Volume:
0.61
Market Cap:
$202.32M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-13.57
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+1.91%
1M Performance:
-6.54%
6M Performance:
+8.46%
1Y Performance:
+3.71%
1-Day Range:
$18.47
$18.81
1-Week Range:
$17.60
$18.96
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.72 | 201.35M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
Using Ichimoku Cloud for MediWound Ltd. technicalsReal-Time AI Sentiment and Price Forecast - Newser
Can MediWound Ltd. hit a new high this monthFree Low Risk Buy Zone Opportunity Watch - Newser
What’s next for MediWound Ltd. stock priceChart Driven Opportunity Scanner with Alerts - Newser
How to integrate MediWound Ltd. into portfolio analysis toolsEntry Signal Generator with Risk Metrics - Newser
Will MediWound Ltd. stock go up soonFree Chart Breakout Buy Signal Detection - Newser
Volatility clustering patterns for MediWound Ltd.Free Step-by-Step Trade Signal Implementation - Newser
Combining machine learning predictions for MediWound Ltd.Free Access to Real-Time Trade Insights - Newser
Can machine learning forecast MediWound Ltd. recoveryReal Time Trade Execution Alert Plan - Newser
Is MediWound Ltd. stock undervalued right nowHigh Earning Swing Trade Alerts - thegnnews.com
Is MediWound Ltd. stock ready for a breakoutFree Investment Strategy With Predictable Gains - Newser
Price action breakdown for MediWound Ltd.Free Reversal Alert Based on RSI Indicator - Newser
Is MediWound Ltd. stock a good hedge against inflationSwing Entry Risk Mitigation with Chart Analysis - Newser
MediWound Ltd. Company’s Quarterly Earnings Growth: What the Numbers SayEarly Entry Planner for Swing Candidates - Newser
Has MediWound Ltd. formed a bullish divergenceFree Triple Digit Return Stock Predictions - Newser
Chart overlay techniques for tracking MediWound Ltd.Free Real Time Alerts Based on AI Prediction - Newser
Detecting support and resistance levels for MediWound Ltd.Yearly Trend Summary and Opportunity Breakdown - Newser
Bank of New York Mellon Corp Increases Stake in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound Ltd. stock outlook for YEARSteady Return Plan Based on Data Analysis - Newser
How to use a screener to detect MediWound Ltd. breakoutsRapid Trade Forecast Based on Indicators - Newser
MediWound Ltd. Breakout Confirmed by Volume MetricsConsistent Return Investment Model Signal - beatles.ru
MediWound to Report Second Quarter 2025 Financial Results | MDWD Stock News - GuruFocus
MediWound Ltd. to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 14 - Quiver Quantitative
MediWound Q2 2025 results to be announced on Aug. 14, conference call scheduled. - AInvest
MediWound to Report Second Quarter 2025 Financial Results - GlobeNewswire
MediWound Earnings: Next-Gen Tissue Repair Leader Sets Q2 2025 Results DateKey Details Inside - Stock Titan
MediWound Ltd. (NASDAQ:MDWD) Looks Just Right With A 26% Price Jump - 富途牛牛
Is it the right time to buy MediWound Ltd. stockFree Trend-Following Techniques - Jammu Links News
How does MediWound Ltd. compare to its industry peersExplosive wealth accumulation - Jammu Links News
What are the latest earnings results for MediWound Ltd.High-profit trading signals - Jammu Links News
What makes MediWound Ltd. stock price move sharplyRapid growth opportunities - Jammu Links News
What markets is VRME expanding into Is MediWound Ltd. stock a good long term investment option - jammulinksnews.com
Investor Network: MediWound Ltd. to Host Earnings Call - ACCESS Newswire
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):